Key result
Vascular Cyclophilin D depletion attenuates angiotensin II-induced hypertension and oxidative stress in mice.
Why the study?
Does depletion of mitochondrial Cyclophilin D in endothelial and smooth muscle cells attenuate vascular dysfunction and hypertension in an angiotensin II mouse model?
Does depletion of mitochondrial Cyclophilin D in endothelial and smooth muscle cells attenuate vascular dysfunction and hypertension in an angiotensin II mouse model?
Answers are grounded in this paper and cite their sources.
Targeting mitochondrial Cyclophilin D in the vasculature reduces oxidative stress and improves vascular function, highlighting a potential therapeutic pathway for hypertension.
Hypertension is a major risk factor of cardiovascular disease affecting nearly half of adult population. It is associated with mitochondrial dysfunction and understanding these mechanisms is important to develop new therapies. Cyclophilin D (CypD) promotes mitochondrial swelling and dysfunction. The objective of this study is to test if CypD depletion attenuates vascular dysfunction and hypertension using endothelial and smooth muscle-specific CypD knockout mice in angiotensin II model of vascular dysfunction and hypertension. Our results show that depletion of endothelial CypD prevents angiotensin II-induced impairment of endothelial-dependent vasorelaxation, preserves endothelial nitric oxide and mitochondrial respiration, attenuates hypertension, vascular oxidative stress and vascular metabolic glycolytic-switch. Depletion of smooth muscle CypD slightly reduces angiotensin II-induced hypertension, protects vascular nitric oxide and vasorelaxation, decreases vascular superoxide, diminishes angiotensin II-induced vascular glycolysis, hypertrophy and fibrosis. These data suggest "metabolic" and "redox" crosstalk between endothelial and smooth muscle cells. Endothelial CypD depletion reduces not only endothelial glycolysis but also attenuates smooth muscle cell glycolytic switch. Smooth muscle CypD depletion reduced not only smooth muscle glycolysis, but it also attenuated endothelial glycolysis. Vascular oxidative stress was inhibited both in EcCypDKO and SmcCypDKO mice, therefore, cell-specific CypD depletion had "global" antioxidant effect in vasculature. Our results support a novel function of mitochondrial CypD in regulation of superoxide and metabolism in vascular smooth muscle and endothelial cells which affect endothelial barrier and smooth muscle vascular functions. We suggest that blocking vascular CypD reduces vascular oxidative stress, improves vascular metabolism and vascular function which may be beneficial in cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Dikalova et al. (2025) studied Vascular dysfunction and hypertension. Depletion of Cyclophilin D (CypD) was evaluated on Vascular dysfunction and hypertension. Depletion of endothelial and smooth muscle Cyclophilin D in mice attenuated angiotensin II-induced hypertension, vascular oxidative stress, and metabolic glycolytic-switch.
Synapse has enriched 10 related papers. Consider them for comparative context: